NCT00432406View on ClinicalTrials.gov

Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Psoriatic Arthritis
Interventions
DRUG

Infliximab

Infliximab 5 mg/kg given at day 1, week 2, week 6

DRUG

Etanercept

Etanercept 25 mg twice weekly

Trial Locations (1)

Unknown

Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT00432406 - Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis | Biotech Hunter | Biotech Hunter